Skip to content

Direct Effect of Caffeine on Diaphragmatic Muscles

Direct Effect of Caffeine on Diaphragmatic Muscles

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04483492
Enrollment
56
Registered
2020-07-23
Start date
2019-03-01
Completion date
2020-12-01
Last updated
2020-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caffeine

Brief summary

The mechanism of methylxanthines is thought to increase chemoreceptor responsiveness to CO2 in central nervous system. Besides, effect of methylxanthines on diaphragmatic contractility has also been found in experimental studies. A study of premature newborns has showed caffeine increase diaphragmatic activity and tidal volume. But, there is limited data about caffeine direct effect on diaphragma. Objective: The investigators aimed to show the direct effect of caffeine on diphragmatic contractility. Method: The babies under 32 weeks with respiratory support, are being enrolled in this study if caffeine treatment is decided to receive. Evaluation of muscle contraction is being made by ultrasound before and 30 minutes after caffeine loading dose. Right and left sides of diaphragm thickness are being measured by two clinicians on B mode ultrasound by anterior subcostal view. The velocity before and after caffeine administration will be calculated, dividing excursion frequency (parameter) for inspiratory time. Movement of the diaphragm at inspiratory and expiratory phases are also observed on M mode and the difference between the two phases are measured.

Interventions

DRUGCaffeine citrate

diaphragm contractility after administration

Sponsors

Hacettepe University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Days to 7 Days
Healthy volunteers
No

Inclusion criteria

* newborns under 32 weeks with respiratory support * caffeine is decided to give

Exclusion criteria

* babies with congenital malformations

Design outcomes

Primary

MeasureTime frameDescription
diphragmatic contractility30 minutesdiphragmatic contractility measured by ultrasonographic evaluation

Countries

Turkey (Türkiye)

Contacts

Primary ContactHasan Tolga Celik, MD
htcelik@gmail.com+905305925584

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026